VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405 - PubMed (original) (raw)
Comparative Study
VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405
M Fines et al. Antimicrob Agents Chemother. 1999 Sep.
Abstract
Enterococcus faecalis BM4405 was resistant to low levels of vancomycin (MIC, 16 microg/ml) and was susceptible to teicoplanin (MIC, 0.5 microg/ml). No PCR product was obtained when the total DNA of this clinical isolate was used as a template with primers specific for glycopeptide resistance genes vanA, vanB, vanC, and vanD. However, a 604-bp PCR fragment was obtained when V1 and V2 degenerate primers were used and total DNA was digested with HindIII as a template. The product was cloned and sequenced. The deduced amino acid sequence had greater identity (55%) with VanC than with VanA (45%), VanB (43%), or VanD (44%). This was consistent with the fact that BM4405 synthesized peptidoglycan precursors that terminated in D-serine residues. After induction with vancomycin, weak D,D-dipeptidase and penicillin-insensitive D,D-carboxypeptidase activities were detected in cytoplasmic extracts of BM4405, whereas a serine racemase activity was found in the membrane preparation. This new type of acquired glycopeptide resistance was named VanE.
Figures
FIG. 1
Sequence of the 604-bp PCR product internal to the vanE gene of E. faecalis BM4405 and the corresponding amino acid sequence.
FIG. 2
Alignment of the deduced partial amino acid sequence of VanE and of the corresponding regions of VanA, VanB, VanC, VanD, and Efa, the
d
-Ala:
d
-Ala ligase of E. faecalis. The amino acids conserved in all the sequences are printed in boldface. Dots indicate gaps introduced to optimize sequence similarity. The conserved motif EKY(Q/N) present in VanC-type and VanE
d
-Ala:
d
-Ser ligases is underlined. GenBank accession numbers are as follows: X56895 for VanA, U35369 for VanB, M75132 for VanC, AF130997 for VanD, AF136925 for VanE, and U00457 for the
d
-Ala:
d
-Ala ligase for E. faecalis.
References
- Arias C A, Martin-Martinez M, Blundell T L, Arthur M, Courvalin P, Reynolds P E. Characterization and modelling of VanT: a novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174. Mol Microbiol. 1999;31:1653–1664. -PubMed
- Arthur M, Reynolds P E, Courvalin P. Glycopeptide resistance in enterococci. Trends Microbiol. 1996;4:401–407. -PubMed
- Arthur M, Depardieu F, Reynolds P, Courvalin P. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol Microbiol. 1996;21:33–44. -PubMed
- Bugg T D H, Wright G D, Dutka-Malen S, Arthur M, Courvalin P, Walsh C T. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry. 1991;30:10408–10415. -PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases